Breast Cancer Risk May Rise With Blood Pressure Medicines
This article is for subscribers only.
Using a type of blood pressure drug for more than a decade may raise breast-cancer risk, a study found, the first potential link between long-term use of the popular medicines and the most common malignancy among women.
Women who took blood pressure drugs called calcium-channel blockers, like Pfizer Inc.’s Norvasc, for 10 years or more had a 2.5 times higher risk of developing breast cancer than those who never took the medicine or who used other blood pressure treatments, according to research published in JAMA Internal Medicine.